Skip to main content
    P

    Pacira BioSciences, Inc. (PCRX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $36.48
    +0.02 (+0.05%)

    Market Cap: $1.46B

    Last updated: Nov 17, 2026 at 3:04 AM ET

    Pacira BioSciences, Inc. (PCRX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Pacira BioSciences (PCRX) has a latest price of $36.48 on Nov 17, 2026, 0.5% below its 52-week high of $36.67. Its price rose 54.4% over the past 12 months. The month-end price rose 14.4% over the 10 years through Oct 2026, a compound annual rate of 1.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $76.32 in Mar 2022 and its lowest $15.05 in Sep 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PCRX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PCRX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 52.0%, and over 6 months it rose 62.6%. The month-end price rose 28.8% over the 3 years through Oct 2026, a compound annual rate of 8.8%.

    PeriodChange
    1 month+0.4%
    3 months+52.0%
    6 months+62.6%
    12 months+54.4%
    12 months, with dividends+54.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+28.8%+8.8%
    5 years-30.4%-7.0%
    10 years+14.4%+1.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 41.3%, and its weakest was 2024, when it fell 44.2%.

    YearCloseChange
    2026 through Oct 2026$36.39+40.6%
    2025$25.88+37.4%
    2024$18.84-44.2%
    2023$33.74-12.6%
    2022$38.61-35.8%
    2021$60.17+0.6%
    2020$59.84+32.1%
    2019$45.30+5.3%
    2018$43.02-5.8%
    2017$45.65+41.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 16.2% above its 50-day average of $31.39 and 41.8% above its 200-day average of $25.73.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$36.48
    52-week high$36.67-0.5%
    52-week low$18.80+94.0%
    50-day average$31.39+16.2%
    200-day average$25.73+41.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 67.0%.

    MeasureValue
    1-year beta0.06
    Largest fall, 1 year-28.2%
    Largest fall, 3 years-67.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Pacira BioSciences traded at 10.9x earnings at the end of 2025, against a 5-year median of 10.9x and a 10-year median of 20.3x.

    PCRX valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PCRX

    What is PCRX's 1-year price change?

    Pacira BioSciences's price rose 54.4% over the past 12 months. With dividends included, the 12-month total return was 54.4%.

    What is PCRX's 5-year price change?

    Pacira BioSciences's month-end price fell 30.4% over the 5 years through Oct 2026, a compound annual decline of 7.0%. These figures leave out dividends.

    What is PCRX's 52-week high and low?

    Pacira BioSciences's 52-week high is $36.67 and its 52-week low is $18.80. Its latest price of $36.48 on Nov 17, 2026 is 0.5% below the high.

    What is PCRX's beta?

    Pacira BioSciences's 1-year beta against the S&P 500 is 0.06, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 28.2%.

    Is the PCRX chart free?

    Yes. Advanced Charting for PCRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.